Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Complex Deep Neural Networks for Denoising Ultra-Fast Submillimeter T2*-weighted Imaging and Quantitative Susceptibility Mapping.

European journal of radiology artificial intelligence·2026
Same author

Challenges and future directions for multiple sclerosis after the 2024 McDonald diagnostic criteria.

Nature medicine·2026
Same author

Evaluation of potential serum biomarkers for individuals at risk of multiple sclerosis.

bioRxiv : the preprint server for biology·2026
Same author

Bruton's tyrosine kinase inhibitors: a new class of multiple sclerosis therapeutics.

The Lancet. Neurology·2026
Same author

Application of the 2024 McDonald Criteria in Individuals With Nonspecific Symptoms or Incidental Imaging Findings in a Multicenter Study.

Neurology·2026
Same author

GPR15-guided CD8<sup>+</sup> T regulatory cells control intestinal inflammation.

Nature·2026

Related Experiment Video

Updated: Jun 24, 2026

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Sensorimotor dysfunction in multiple sclerosis and column-specific magnetization transfer-imaging abnormalities in

Kathleen M Zackowski1, Seth A Smith, Daniel S Reich

  • 1Department of Physical Medicine and Rehabilitation, Johns Hopkins University, 600 N Wolfe St, Baltimore, MD 21287, USA. zackowski@kennedykrieger.org

Brain : a Journal of Neurology
|March 20, 2009
PubMed
Summary

A new MRI technique precisely quantifies spinal cord damage in multiple sclerosis (MS), linking specific white matter column injury to distinct sensorimotor deficits like impaired sensation and reduced strength.

More Related Videos

Diffusion Tensor Magnetic Resonance Imaging in Chronic Spinal Cord Compression
07:00

Diffusion Tensor Magnetic Resonance Imaging in Chronic Spinal Cord Compression

Published on: May 7, 2019

Standing Neurophysiological Assessment of Lower Extremity Muscles Post-Stroke
08:23

Standing Neurophysiological Assessment of Lower Extremity Muscles Post-Stroke

Published on: July 26, 2021

Related Experiment Videos

Last Updated: Jun 24, 2026

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Diffusion Tensor Magnetic Resonance Imaging in Chronic Spinal Cord Compression
07:00

Diffusion Tensor Magnetic Resonance Imaging in Chronic Spinal Cord Compression

Published on: May 7, 2019

Standing Neurophysiological Assessment of Lower Extremity Muscles Post-Stroke
08:23

Standing Neurophysiological Assessment of Lower Extremity Muscles Post-Stroke

Published on: July 26, 2021

Area of Science:

  • Neuroimaging
  • Neurology
  • Biomedical Engineering

Background:

  • Conventional MRI struggles to quantify spinal cord damage in multiple sclerosis (MS).
  • MS lesions have varied pathologies, complicating the link between MRI findings and clinical symptoms.
  • Sensorimotor impairment is a hallmark of MS, but its precise anatomical basis in the spinal cord remains unclear.

Purpose of the Study:

  • To develop and apply a novel magnetization-transfer-weighted imaging (MTI) approach for quantifying spinal white matter damage in MS.
  • To investigate the association between MTI-derived measures of spinal cord white matter integrity and sensorimotor function in individuals with MS.
  • To explore the relationship between spinal cord MRI abnormalities and clinical measures of sensation, strength, and mobility.

Main Methods:

  • 42 participants with MS underwent 3 Tesla MRI and comprehensive sensorimotor assessments.
  • Cerebrospinal-fluid-normalized magnetization-transfer signals were measured in the dorsal and lateral columns of the cervical spinal cord.
  • Linear regression and stepwise multiple regression analyses were used to correlate MRI findings with clinical outcomes, including vibration sensation, strength, walking velocity, and balance.

Main Results:

  • Dorsal column MTI signal strongly correlated with vibration sensation (R = 0.58, P < 0.001).
  • Lateral column MTI signal correlated with muscle strength (R = -0.45, P = 0.003).
  • Spinal cord MTI measures also showed significant correlations with walking and balance impairments.

Conclusions:

  • Novel MTI technique effectively quantifies spinal white matter damage in MS.
  • Specific spinal cord white matter columns are anatomically linked to distinct sensorimotor deficits in MS.
  • These findings provide a better understanding of the neural basis of MS-related disability and inform clinical trial design for neuroprotective therapies.